Analysis of Solvency Ratios
Solvency ratios also known as long-term debt ratios measure a company ability to meet long-term obligations.
Solvency Ratios (Summary)
AmerisourceBergen Corp., solvency ratios
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to capital ratio | A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. | AmerisourceBergen Corp. debt to capital ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
| Debt to capital ratio (including operating lease liability) | A solvency ratio calculated as total debt (including operating lease liability) divided by total debt (including operating lease liability) plus shareholders’ equity. | AmerisourceBergen Corp. debt to capital ratio (including operating lease liability) improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
| Debt to assets ratio | A solvency ratio calculated as total debt divided by total assets. | AmerisourceBergen Corp. debt to assets ratio deteriorated from 2020 to 2021 but then improved from 2021 to 2022 not reaching 2020 level. |
| Debt to assets ratio (including operating lease liability) | A solvency ratio calculated as total debt (including operating lease liability) divided by total assets. | AmerisourceBergen Corp. debt to assets ratio (including operating lease liability) deteriorated from 2020 to 2021 but then improved from 2021 to 2022 not reaching 2020 level. |
| Solvency ratio | Description | The company |
|---|---|---|
| Interest coverage ratio | A solvency ratio calculated as EBIT divided by interest payments. | AmerisourceBergen Corp. interest coverage ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
| Fixed charge coverage ratio | A solvency ratio calculated as earnings before fixed charges and tax divided by fixed charges. | AmerisourceBergen Corp. fixed charge coverage ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
Debt to Equity
AmerisourceBergen Corp., debt to equity calculation, comparison to benchmarks
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Short-term debt | 1,070,473) | 300,213) | 501,259) | 139,012) | 151,657) | 12,121) | |
| Long-term debt, net of current portion | 4,632,360) | 6,383,711) | 3,618,261) | 4,033,880) | 4,158,532) | 3,429,934) | |
| Total debt | 5,702,833) | 6,683,924) | 4,119,520) | 4,172,892) | 4,310,189) | 3,442,055) | |
| Total AmerisourceBergen Corporation stockholders’ equity (deficit) | (211,559) | 223,354) | (1,018,924) | 2,878,917) | 2,932,824) | 2,064,461) | |
| Solvency Ratio | |||||||
| Debt to equity1 | — | 29.93 | — | 1.45 | 1.47 | 1.67 | |
| Benchmarks | |||||||
| Debt to Equity, Competitors2 | |||||||
| Abbott Laboratories | 0.46 | 0.50 | 0.57 | 0.58 | — | — | |
| Cigna Group | 0.69 | 0.71 | 0.65 | 0.83 | — | — | |
| CVS Health Corp. | 0.74 | 0.75 | 0.93 | 1.07 | — | — | |
| Elevance Health Inc. | 0.66 | 0.64 | 0.60 | 0.63 | — | — | |
| Intuitive Surgical Inc. | 0.00 | 0.00 | 0.00 | 0.00 | — | — | |
| Medtronic PLC | 0.46 | 0.51 | 0.49 | 0.51 | — | — | |
| UnitedHealth Group Inc. | 0.74 | 0.64 | 0.66 | 0.71 | — | — | |
| Debt to Equity, Sector | |||||||
| Health Care Equipment & Services | 0.62 | 0.62 | 0.66 | — | — | — | |
| Debt to Equity, Industry | |||||||
| Health Care | 0.72 | 0.79 | 0.90 | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Debt to equity = Total debt ÷ Total AmerisourceBergen Corporation stockholders’ equity (deficit)
= 5,702,833 ÷ -211,559 = —
2 Click competitor name to see calculations.
Debt to Equity (including Operating Lease Liability)
AmerisourceBergen Corp., debt to equity (including operating lease liability) calculation, comparison to benchmarks
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Short-term debt | 1,070,473) | 300,213) | 501,259) | 139,012) | 151,657) | 12,121) | |
| Long-term debt, net of current portion | 4,632,360) | 6,383,711) | 3,618,261) | 4,033,880) | 4,158,532) | 3,429,934) | |
| Total debt | 5,702,833) | 6,683,924) | 4,119,520) | 4,172,892) | 4,310,189) | 3,442,055) | |
| Operating lease liabilities (included in Accrued expenses and other) | 158,184) | 175,352) | 92,587) | —) | —) | —) | |
| Operating lease liabilities (included in Other long-term liabilities) | 864,288) | 946,155) | 385,507) | —) | —) | —) | |
| Total debt (including operating lease liability) | 6,725,305) | 7,805,431) | 4,597,614) | 4,172,892) | 4,310,189) | 3,442,055) | |
| Total AmerisourceBergen Corporation stockholders’ equity (deficit) | (211,559) | 223,354) | (1,018,924) | 2,878,917) | 2,932,824) | 2,064,461) | |
| Solvency Ratio | |||||||
| Debt to equity (including operating lease liability)1 | — | 34.95 | — | 1.45 | 1.47 | 1.67 | |
| Benchmarks | |||||||
| Debt to Equity (including Operating Lease Liability), Competitors2 | |||||||
| Abbott Laboratories | 0.49 | 0.54 | 0.61 | 0.61 | — | — | |
| Cigna Group | 0.70 | 0.73 | 0.67 | 0.84 | — | — | |
| CVS Health Corp. | 1.00 | 1.01 | 1.23 | 1.39 | — | — | |
| Elevance Health Inc. | 0.69 | 0.67 | 0.63 | 0.65 | — | — | |
| Intuitive Surgical Inc. | 0.01 | 0.01 | 0.01 | 0.01 | — | — | |
| Medtronic PLC | 0.48 | 0.53 | 0.51 | 0.51 | — | — | |
| UnitedHealth Group Inc. | 0.80 | 0.70 | 0.73 | 0.77 | — | — | |
| Debt to Equity (including Operating Lease Liability), Sector | |||||||
| Health Care Equipment & Services | 0.70 | 0.70 | 0.75 | — | — | — | |
| Debt to Equity (including Operating Lease Liability), Industry | |||||||
| Health Care | 0.78 | 0.84 | 0.96 | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Debt to equity (including operating lease liability) = Total debt (including operating lease liability) ÷ Total AmerisourceBergen Corporation stockholders’ equity (deficit)
= 6,725,305 ÷ -211,559 = —
2 Click competitor name to see calculations.
Debt to Capital
AmerisourceBergen Corp., debt to capital calculation, comparison to benchmarks
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Short-term debt | 1,070,473) | 300,213) | 501,259) | 139,012) | 151,657) | 12,121) | |
| Long-term debt, net of current portion | 4,632,360) | 6,383,711) | 3,618,261) | 4,033,880) | 4,158,532) | 3,429,934) | |
| Total debt | 5,702,833) | 6,683,924) | 4,119,520) | 4,172,892) | 4,310,189) | 3,442,055) | |
| Total AmerisourceBergen Corporation stockholders’ equity (deficit) | (211,559) | 223,354) | (1,018,924) | 2,878,917) | 2,932,824) | 2,064,461) | |
| Total capital | 5,491,274) | 6,907,278) | 3,100,596) | 7,051,809) | 7,243,013) | 5,506,516) | |
| Solvency Ratio | |||||||
| Debt to capital1 | 1.04 | 0.97 | 1.33 | 0.59 | 0.60 | 0.63 | |
| Benchmarks | |||||||
| Debt to Capital, Competitors2 | |||||||
| Abbott Laboratories | 0.31 | 0.34 | 0.36 | 0.37 | — | — | |
| Cigna Group | 0.41 | 0.42 | 0.40 | 0.45 | — | — | |
| CVS Health Corp. | 0.42 | 0.43 | 0.48 | 0.52 | — | — | |
| Elevance Health Inc. | 0.40 | 0.39 | 0.38 | 0.39 | — | — | |
| Intuitive Surgical Inc. | 0.00 | 0.00 | 0.00 | 0.00 | — | — | |
| Medtronic PLC | 0.31 | 0.34 | 0.33 | 0.34 | — | — | |
| UnitedHealth Group Inc. | 0.43 | 0.39 | 0.40 | 0.41 | — | — | |
| Debt to Capital, Sector | |||||||
| Health Care Equipment & Services | 0.38 | 0.38 | 0.40 | — | — | — | |
| Debt to Capital, Industry | |||||||
| Health Care | 0.42 | 0.44 | 0.47 | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Debt to capital = Total debt ÷ Total capital
= 5,702,833 ÷ 5,491,274 = 1.04
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to capital ratio | A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. | AmerisourceBergen Corp. debt to capital ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
Debt to Capital (including Operating Lease Liability)
AmerisourceBergen Corp., debt to capital (including operating lease liability) calculation, comparison to benchmarks
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Short-term debt | 1,070,473) | 300,213) | 501,259) | 139,012) | 151,657) | 12,121) | |
| Long-term debt, net of current portion | 4,632,360) | 6,383,711) | 3,618,261) | 4,033,880) | 4,158,532) | 3,429,934) | |
| Total debt | 5,702,833) | 6,683,924) | 4,119,520) | 4,172,892) | 4,310,189) | 3,442,055) | |
| Operating lease liabilities (included in Accrued expenses and other) | 158,184) | 175,352) | 92,587) | —) | —) | —) | |
| Operating lease liabilities (included in Other long-term liabilities) | 864,288) | 946,155) | 385,507) | —) | —) | —) | |
| Total debt (including operating lease liability) | 6,725,305) | 7,805,431) | 4,597,614) | 4,172,892) | 4,310,189) | 3,442,055) | |
| Total AmerisourceBergen Corporation stockholders’ equity (deficit) | (211,559) | 223,354) | (1,018,924) | 2,878,917) | 2,932,824) | 2,064,461) | |
| Total capital (including operating lease liability) | 6,513,746) | 8,028,785) | 3,578,690) | 7,051,809) | 7,243,013) | 5,506,516) | |
| Solvency Ratio | |||||||
| Debt to capital (including operating lease liability)1 | 1.03 | 0.97 | 1.28 | 0.59 | 0.60 | 0.63 | |
| Benchmarks | |||||||
| Debt to Capital (including Operating Lease Liability), Competitors2 | |||||||
| Abbott Laboratories | 0.33 | 0.35 | 0.38 | 0.38 | — | — | |
| Cigna Group | 0.41 | 0.42 | 0.40 | 0.46 | — | — | |
| CVS Health Corp. | 0.50 | 0.50 | 0.55 | 0.58 | — | — | |
| Elevance Health Inc. | 0.41 | 0.40 | 0.39 | 0.40 | — | — | |
| Intuitive Surgical Inc. | 0.01 | 0.01 | 0.01 | 0.01 | — | — | |
| Medtronic PLC | 0.32 | 0.35 | 0.34 | 0.34 | — | — | |
| UnitedHealth Group Inc. | 0.45 | 0.41 | 0.42 | 0.44 | — | — | |
| Debt to Capital (including Operating Lease Liability), Sector | |||||||
| Health Care Equipment & Services | 0.41 | 0.41 | 0.43 | — | — | — | |
| Debt to Capital (including Operating Lease Liability), Industry | |||||||
| Health Care | 0.44 | 0.46 | 0.49 | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Debt to capital (including operating lease liability) = Total debt (including operating lease liability) ÷ Total capital (including operating lease liability)
= 6,725,305 ÷ 6,513,746 = 1.03
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to capital ratio (including operating lease liability) | A solvency ratio calculated as total debt (including operating lease liability) divided by total debt (including operating lease liability) plus shareholders’ equity. | AmerisourceBergen Corp. debt to capital ratio (including operating lease liability) improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
Debt to Assets
AmerisourceBergen Corp., debt to assets calculation, comparison to benchmarks
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Short-term debt | 1,070,473) | 300,213) | 501,259) | 139,012) | 151,657) | 12,121) | |
| Long-term debt, net of current portion | 4,632,360) | 6,383,711) | 3,618,261) | 4,033,880) | 4,158,532) | 3,429,934) | |
| Total debt | 5,702,833) | 6,683,924) | 4,119,520) | 4,172,892) | 4,310,189) | 3,442,055) | |
| Total assets | 56,560,616) | 57,337,805) | 44,274,830) | 39,171,980) | 37,669,838) | 35,316,470) | |
| Solvency Ratio | |||||||
| Debt to assets1 | 0.10 | 0.12 | 0.09 | 0.11 | 0.11 | 0.10 | |
| Benchmarks | |||||||
| Debt to Assets, Competitors2 | |||||||
| Abbott Laboratories | 0.23 | 0.24 | 0.26 | 0.27 | — | — | |
| Cigna Group | 0.22 | 0.22 | 0.21 | 0.24 | — | — | |
| CVS Health Corp. | 0.23 | 0.24 | 0.28 | 0.31 | — | — | |
| Elevance Health Inc. | 0.23 | 0.24 | 0.23 | 0.26 | — | — | |
| Intuitive Surgical Inc. | 0.00 | 0.00 | 0.00 | 0.00 | — | — | |
| Medtronic PLC | 0.27 | 0.28 | 0.27 | 0.28 | — | — | |
| UnitedHealth Group Inc. | 0.23 | 0.22 | 0.22 | 0.23 | — | — | |
| Debt to Assets, Sector | |||||||
| Health Care Equipment & Services | 0.23 | 0.23 | 0.24 | — | — | — | |
| Debt to Assets, Industry | |||||||
| Health Care | 0.27 | 0.28 | 0.31 | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Debt to assets = Total debt ÷ Total assets
= 5,702,833 ÷ 56,560,616 = 0.10
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to assets ratio | A solvency ratio calculated as total debt divided by total assets. | AmerisourceBergen Corp. debt to assets ratio deteriorated from 2020 to 2021 but then improved from 2021 to 2022 not reaching 2020 level. |
Debt to Assets (including Operating Lease Liability)
AmerisourceBergen Corp., debt to assets (including operating lease liability) calculation, comparison to benchmarks
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Short-term debt | 1,070,473) | 300,213) | 501,259) | 139,012) | 151,657) | 12,121) | |
| Long-term debt, net of current portion | 4,632,360) | 6,383,711) | 3,618,261) | 4,033,880) | 4,158,532) | 3,429,934) | |
| Total debt | 5,702,833) | 6,683,924) | 4,119,520) | 4,172,892) | 4,310,189) | 3,442,055) | |
| Operating lease liabilities (included in Accrued expenses and other) | 158,184) | 175,352) | 92,587) | —) | —) | —) | |
| Operating lease liabilities (included in Other long-term liabilities) | 864,288) | 946,155) | 385,507) | —) | —) | —) | |
| Total debt (including operating lease liability) | 6,725,305) | 7,805,431) | 4,597,614) | 4,172,892) | 4,310,189) | 3,442,055) | |
| Total assets | 56,560,616) | 57,337,805) | 44,274,830) | 39,171,980) | 37,669,838) | 35,316,470) | |
| Solvency Ratio | |||||||
| Debt to assets (including operating lease liability)1 | 0.12 | 0.14 | 0.10 | 0.11 | 0.11 | 0.10 | |
| Benchmarks | |||||||
| Debt to Assets (including Operating Lease Liability), Competitors2 | |||||||
| Abbott Laboratories | 0.24 | 0.26 | 0.27 | 0.28 | — | — | |
| Cigna Group | 0.22 | 0.22 | 0.22 | 0.24 | — | — | |
| CVS Health Corp. | 0.31 | 0.33 | 0.37 | 0.40 | — | — | |
| Elevance Health Inc. | 0.24 | 0.25 | 0.24 | 0.27 | — | — | |
| Intuitive Surgical Inc. | 0.01 | 0.01 | 0.01 | 0.01 | — | — | |
| Medtronic PLC | 0.27 | 0.29 | 0.28 | 0.28 | — | — | |
| UnitedHealth Group Inc. | 0.25 | 0.24 | 0.24 | 0.26 | — | — | |
| Debt to Assets (including Operating Lease Liability), Sector | |||||||
| Health Care Equipment & Services | 0.26 | 0.26 | 0.28 | — | — | — | |
| Debt to Assets (including Operating Lease Liability), Industry | |||||||
| Health Care | 0.29 | 0.30 | 0.33 | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Debt to assets (including operating lease liability) = Total debt (including operating lease liability) ÷ Total assets
= 6,725,305 ÷ 56,560,616 = 0.12
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to assets ratio (including operating lease liability) | A solvency ratio calculated as total debt (including operating lease liability) divided by total assets. | AmerisourceBergen Corp. debt to assets ratio (including operating lease liability) deteriorated from 2020 to 2021 but then improved from 2021 to 2022 not reaching 2020 level. |
Financial Leverage
AmerisourceBergen Corp., financial leverage calculation, comparison to benchmarks
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Total assets | 56,560,616) | 57,337,805) | 44,274,830) | 39,171,980) | 37,669,838) | 35,316,470) | |
| Total AmerisourceBergen Corporation stockholders’ equity (deficit) | (211,559) | 223,354) | (1,018,924) | 2,878,917) | 2,932,824) | 2,064,461) | |
| Solvency Ratio | |||||||
| Financial leverage1 | — | 256.71 | — | 13.61 | 12.84 | 17.11 | |
| Benchmarks | |||||||
| Financial Leverage, Competitors2 | |||||||
| Abbott Laboratories | 2.03 | 2.10 | 2.21 | 2.18 | — | — | |
| Cigna Group | 3.21 | 3.29 | 3.09 | 3.44 | — | — | |
| CVS Health Corp. | 3.21 | 3.10 | 3.32 | 3.48 | — | — | |
| Elevance Health Inc. | 2.83 | 2.70 | 2.61 | 2.44 | — | — | |
| Intuitive Surgical Inc. | 1.17 | 1.14 | 1.15 | 1.18 | — | — | |
| Medtronic PLC | 1.73 | 1.81 | 1.79 | 1.79 | — | — | |
| UnitedHealth Group Inc. | 3.16 | 2.96 | 3.01 | 3.02 | — | — | |
| Financial Leverage, Sector | |||||||
| Health Care Equipment & Services | 2.72 | 2.67 | 2.71 | — | — | — | |
| Financial Leverage, Industry | |||||||
| Health Care | 2.67 | 2.77 | 2.94 | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Financial leverage = Total assets ÷ Total AmerisourceBergen Corporation stockholders’ equity (deficit)
= 56,560,616 ÷ -211,559 = —
2 Click competitor name to see calculations.
Interest Coverage
AmerisourceBergen Corp., interest coverage calculation, comparison to benchmarks
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Net income (loss) attributable to AmerisourceBergen Corporation | 1,698,820) | 1,539,932) | (3,408,716) | 855,365) | 1,658,405) | 364,484) | |
| Add: Net income attributable to noncontrolling interest | (32,280) | 4,676) | 9,158) | (1,230) | (42,513) | —) | |
| Add: Income tax expense | 516,517) | 677,251) | (1,894,273) | 112,971) | (438,469) | 553,403) | |
| Add: Interest expense | 231,982) | 182,544) | 158,522) | 195,474) | 189,640) | 149,042) | |
| Earnings before interest and tax (EBIT) | 2,415,039) | 2,404,403) | (5,135,309) | 1,162,580) | 1,367,063) | 1,066,929) | |
| Solvency Ratio | |||||||
| Interest coverage1 | 10.41 | 13.17 | -32.39 | 5.95 | 7.21 | 7.16 | |
| Benchmarks | |||||||
| Interest Coverage, Competitors2 | |||||||
| Abbott Laboratories | 15.89 | 16.41 | 10.10 | 7.09 | — | — | |
| Cigna Group | 7.43 | 6.22 | 8.76 | 5.11 | — | — | |
| CVS Health Corp. | 3.46 | 5.16 | 4.36 | 3.96 | — | — | |
| Elevance Health Inc. | 10.13 | 10.93 | 8.96 | 9.02 | — | — | |
| Intuitive Surgical Inc. | — | — | — | — | — | — | |
| Medtronic PLC | 10.98 | 5.21 | 4.71 | 4.60 | — | — | |
| UnitedHealth Group Inc. | 13.59 | 14.44 | 13.47 | 11.55 | — | — | |
| Interest Coverage, Sector | |||||||
| Health Care Equipment & Services | 9.31 | 8.96 | 7.89 | — | — | — | |
| Interest Coverage, Industry | |||||||
| Health Care | 12.71 | 12.24 | 7.71 | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Interest coverage = EBIT ÷ Interest expense
= 2,415,039 ÷ 231,982 = 10.41
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Interest coverage ratio | A solvency ratio calculated as EBIT divided by interest payments. | AmerisourceBergen Corp. interest coverage ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
Fixed Charge Coverage
AmerisourceBergen Corp., fixed charge coverage calculation, comparison to benchmarks
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Net income (loss) attributable to AmerisourceBergen Corporation | 1,698,820) | 1,539,932) | (3,408,716) | 855,365) | 1,658,405) | 364,484) | |
| Add: Net income attributable to noncontrolling interest | (32,280) | 4,676) | 9,158) | (1,230) | (42,513) | —) | |
| Add: Income tax expense | 516,517) | 677,251) | (1,894,273) | 112,971) | (438,469) | 553,403) | |
| Add: Interest expense | 231,982) | 182,544) | 158,522) | 195,474) | 189,640) | 149,042) | |
| Earnings before interest and tax (EBIT) | 2,415,039) | 2,404,403) | (5,135,309) | 1,162,580) | 1,367,063) | 1,066,929) | |
| Add: Operating lease cost | 220,935) | 161,054) | 118,144) | 108,900) | 114,900) | 80,700) | |
| Earnings before fixed charges and tax | 2,635,974) | 2,565,457) | (5,017,165) | 1,271,480) | 1,481,963) | 1,147,629) | |
| Interest expense | 231,982) | 182,544) | 158,522) | 195,474) | 189,640) | 149,042) | |
| Operating lease cost | 220,935) | 161,054) | 118,144) | 108,900) | 114,900) | 80,700) | |
| Fixed charges | 452,917) | 343,598) | 276,666) | 304,374) | 304,540) | 229,742) | |
| Solvency Ratio | |||||||
| Fixed charge coverage1 | 5.82 | 7.47 | -18.13 | 4.18 | 4.87 | 5.00 | |
| Benchmarks | |||||||
| Fixed Charge Coverage, Competitors2 | |||||||
| Abbott Laboratories | 10.10 | 10.21 | 6.68 | 5.14 | — | — | |
| Cigna Group | 6.87 | 5.61 | 7.84 | 4.67 | — | — | |
| CVS Health Corp. | 2.16 | 3.03 | 2.75 | 2.56 | — | — | |
| Elevance Health Inc. | 8.82 | 8.48 | 6.10 | 7.34 | — | — | |
| Intuitive Surgical Inc. | 63.52 | 93.66 | 58.48 | 79.65 | — | — | |
| Medtronic PLC | 7.79 | 4.31 | 3.98 | 3.97 | — | — | |
| UnitedHealth Group Inc. | 8.77 | 8.80 | 8.51 | 7.65 | — | — | |
| Fixed Charge Coverage, Sector | |||||||
| Health Care Equipment & Services | 6.11 | 5.87 | 5.31 | — | — | — | |
| Fixed Charge Coverage, Industry | |||||||
| Health Care | 9.02 | 8.67 | 5.70 | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Fixed charge coverage = Earnings before fixed charges and tax ÷ Fixed charges
= 2,635,974 ÷ 452,917 = 5.82
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Fixed charge coverage ratio | A solvency ratio calculated as earnings before fixed charges and tax divided by fixed charges. | AmerisourceBergen Corp. fixed charge coverage ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |